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Abstract- Fatty liver disease (FLD) is the most prevalent form of liver disease worldwide. Overnutrition can 
induce nonalcoholic fatty liver disease (NAFLD), a spectrum of conditions ranging from simple steatosis [or 
nonalcoholic fatty liver (NAFL)] to nonalcoholic steatohepatitis and cirrhosis. Some of the epidemiological 
and pathological studies have also suggested an association between the presence of fatty liver and sudden 
death. A 37-year-old man was found dead when he was asleep in the bed at home. According to his family, he 
was single and a costermonger. He was not an athlete, and there was no history of any physical and mental 
disorder. He was not addicted and did not use any drugs or alcohol. The positive points, in this case, were: a 
large heart with mild coronary stenosis and steatohepatitis in autopsy and sudden death. Since steatohepatitis 
did not have any complication such as fat embolism, it can be concluded that the combination of 
steatohepatitis and cardiovascular disorder led to sudden unexpected death. Heart more than 450 gr is 
susceptible to arrhythmia, and fatty liver disease can cause cardiovascular changes. 
© 2016 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Fatty liver disease (FLD) is the most prevalent form 
of liver disease worldwide. Overnutrition and excessive 
alcohol consumption are two major causes of FLD. 
Overnutrition can induce nonalcoholic fatty liver disease 
(NAFLD), a spectrum of conditions ranging from simple 
steatosis [or nonalcoholic fatty liver (NAFL)] to 
nonalcoholic steatohepatitis and cirrhosis (1).  
The diagnosis of NAFLD and non-alcoholic 
steatohepatitis (NASH) is based on histological 
findings (2). 
Cases of fatty liver disease with inflammation that 
resembled alcoholic steatohepatitis but occurring in 
nondrinkers were described 30 years ago, first in the 
Japanese literature and then in the United States (3-4).  
As patients with NAFLD are enriched with risk 
factors known to cause and exacerbate atherosclerosis, it 
has been suspected that individuals with NAFLD are at 
heightened risk for cardiovascular disease (5). 
Some of the epidemiological and pathological 
studies have also suggested an association between the 
presence of fatty liver and sudden death (6). 
 On the whole, patients with NAFLD die of liver-
related causes to a greater extent than the general 
population, but we still see cardiovascular disease and 
extrahepatic malignancies be the primary and secondary 
causes of deaths among these patients (7). 
The presence of hepatic steatosis (rather than 
subtypes of NAFLD) seems to be the main risk factor 
for cardiovascular mortality in patients with NAFLD 
(8). 
 
Case Report 
 
A 37-year-old man was found dead in the bed at 
home. According to his family, he was single and a 
costermonger. He was not an athlete, and there was no 
history of any physical and mental disorder. He was not 
addicted and did not use any drugs and alcohol. In 
postmortem examination, his weight was 90 kg. Less 
than 24 hours have passed since death. There was no 
significant finding in the corpse appearance. In autopsy, 
the heart was larger than normal with the weight of 480 
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g and Mild stenosis was detected in coronary arteries. 
There was no significant change in the myocardium, 
endocardium, and the valves. The liver was larger than 
the normal size with yellow-brown color. Microscopic 
pathology evaluation of the liver revealed 
steatohepatitis. There was no significant abnormal 
finding in the other organs. Toxicology was negative. 
According to the postmortem examination, autopsy 
findings (microscopy and microscopy) and the result of 
the lab toxicology, the cause of death   association 
between NAFLD and a mildly enlarged heart, was 
determined. 
 
Discussion 
 
Several recent studies have shown that adults and 
children with NAFLD are enriched with risk factors that 
are generally accepted as surrogates for the risk of 
cardiovascular disease. Various surrogates used in clinical 
studies include Framingham Risk Score (consisting age, 
gender, hypertension, smoking, and hyperlipidemia), 
carotid artery intima-media thickness, hsCRP, atheroma 
formation, mediastinal fat pad, endothelial dysfunction, 
and coronary calcium scores (9). 
Cardiovascular disease is one of the most important 
causes of morbidity and mortality in patients with 
NAFLD. In a study consisting of 132 patients with 
biopsy-proven NAFLD followed for 18 years, 
cardiovascular disease was the second most common 
cause of deaths after all of the cancers combined (10). 
Patients with NAFLD have very high prevalence of 
cardiac risk factors, and several recent studies have 
shown that cardiovascular morbidity and mortality are in 
fact more important than hepatic adverse events in the 
patient population (9). 
 People with NAFLD have a higher chance of 
developing type 2 diabetes and cardiovascular disease 
(this includes heart attacks and strokes) (11). 
Anyone with a heart weighing more than 450 g is a 
candidate for sudden death with or without coronary 
artery stenosis. The mechanism of this sudden type of 
death, where there is no large infarct, seems to be a state 
of electrical instability from chronic hypoxia though it 
must be said that death can occur while the victim is 
asleep or at rest (12). 
 The positive point, in this case, was: a large heart, 
steatohepatitis, and sudden death. Since steatohepatitis 
did not have any complication such as fat embolism, it 
can be concluded that the combination of steatohepatitis 
and cardiovascular disorder led to sudden unexpected 
death. Heart more than 450g is susceptible to 
arrhythmia, and fatty liver disease can cause 
cardiovascular changes.  
 Healthcare providers should recognize this 
heightened cardiovascular risk. Mohammad Ebrahim 
Ghamar-Chehreh et al found that family history for 
cardiovascular disease,diabetes,dyslipidemia,and 
hypertention are of clinical importance in NAFLD 
patient population(13). Patients should be educated as it 
is our experience that they become singularly focused on 
liver enzymes and ignore more important cardiovascular 
health. Weights lose, and optimal management of 
diabetes and dyslipidemia would improve hepatic 
histology and also improve cardiovascular morbidity (7). 
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